HeartFlow
1400 Seaport Blvd
Building B
Redwood City , CA 94063
USA
Phone: 650.241.1221
[email protected]
Visit Website
Product Categories:
Advanced Visualization, FFR Technologies

Related Content

HeartFlow announced that new data on HeartFlow Plaque Analysis and its RoadMap Analysis will be presented at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Boston, MA.
News | SCCT
HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting

July 25, 2023 — HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and ...

Home July 25, 2023
arrow
HeartFlow is the first and only company to provide non-invasive anatomy, physiology, and plaque information based on coronary computed tomography angiography (CCTA)
News | Cardiac Imaging
HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap Analysis

October 18, 2022 — HeartFlow, Inc., a leader in revolutionizing precision heart care, has received U.S. Food and Drug ...

Home October 18, 2022
arrow
The first dataset - HeartFlow’s largest study to date - studied over 11,800 patients and enables physicians to understand a patient's burden of coronary plaque compared to their age and sex-matched peers
News | SCCT
New Plaque Clinical Data Provides Additional Insights on Anatomy and Physiology in Clinical Decision Making for Patients

July 22, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, released two datasets utilizing its ...

Home July 22, 2022
arrow
John Farquhar
News | Cardiovascular Business
HeartFlow Announces CEO Transition

March 2, 2022 – HeartFlow, Inc. has announced that John Farquhar has been appointed President and Chief Executive ...

Home March 02, 2022
arrow
Videos | Cardiac Imaging
VIDEO: The Role of FFR-CT Under the New Chest Pain Evaluation Guidelines

Interview with Campbell Rogers, M.D., chief medical officer of HeartFlow which has developed a CT image-based fractional ...

Home February 01, 2022
arrow
Videos | Coronavirus (COVID-19)
VIDEO: FFR-CT May Aid Patient Assessments in the COVID Era

Campbell Rogers, M.D., chief medical officer of HeartFlow, explains how hospitals are using CT image-based fractional ...

Home February 01, 2022
arrow
An example of HeartFlow's FFR-CT assessment, which shows areas of low blood flow based on computation fluid dynamics from a CT scan of the heart. The vendor's new PreRead software will use AI to clearly and reproducibly identify areas of ischemia due to coronary artery occlusion and act as a second set of eyes for emergency rooms evlautaing chest pain patients. 
News | FFR Technologies
HeartFlow Files for FDA Review to Evaluate the Coronary Occlusions and Plaque

December 13, 2021 - HeartFlow Inc., the leader in revolutionizing precision heart care, today announced it has submitted ...

Home December 13, 2021
arrow
HeartFlow, Inc., a leader in revolutionizing precision heart care, announced the commencement of the REVEALPLAQUE (A pRospEctiVe, multicEnter study to AnaLyze PLAQUE using CCTA) trial to evaluate HeartFlow’s non-invasive plaque technology, an automated, deep learning-based method for identifying, characterizing and segmenting plaque in the coronary arteries
News | Computed Tomography (CT)
HeartFlow Announces Enrollment of First Two Patients in REVEALPLAQUE Trial

October 20, 2021 — HeartFlow Inc. announced the commencement of the REVEALPLAQUE (A pRospEctiVe, multicEnter study to ...

Home October 20, 2021
arrow
An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.
News | FFR Technologies
HeartFlow Becomes Publicly Traded Company in Merger With Longview Acquisition Corp.

July 15, 2021 — HeartFlow, which has commercialized noninvasive computed tomography derived fractional flow reserve (FFR ...

Home July 15, 2021
arrow
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone actually was not flow limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings. #TCT2020 #TCTconnect
News | FFR Technologies| Dave Fornell, Editor
FFR-CT Did Not Significantly Reduce Costs But Reduced Rates of Invasive Coronary Angiography

October 22, 2020 – In the FORECAST randomized clinical trial, the use of fractional flow reserve (FFR) derived from ...

Home October 22, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now